These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 17249692

  • 1. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
    Celik L, Lund JD, Schiøtt B.
    Biochemistry; 2007 Feb 20; 46(7):1743-58. PubMed ID: 17249692
    [Abstract] [Full Text] [Related]

  • 2. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.
    Zeng J, Li W, Zhao Y, Liu G, Tang Y, Jiang H.
    J Phys Chem B; 2008 Mar 06; 112(9):2719-26. PubMed ID: 18266357
    [Abstract] [Full Text] [Related]

  • 3. Characterization of agonist binding to His524 in the estrogen receptor α ligand binding domain.
    Gao L, Tu Y, Ågren H, Eriksson LA.
    J Phys Chem B; 2012 Apr 26; 116(16):4823-30. PubMed ID: 22482773
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
    Jin KS, Park JK, Yoon J, Rho Y, Kim JH, Kim EE, Ree M.
    J Phys Chem B; 2008 Aug 14; 112(32):9603-12. PubMed ID: 18646811
    [Abstract] [Full Text] [Related]

  • 6. Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha.
    Chakraborty S, Levenson AS, Biswas PK.
    BMC Struct Biol; 2013 Oct 25; 13():27. PubMed ID: 24160181
    [Abstract] [Full Text] [Related]

  • 7. Activation helix orientation of the estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations.
    Fratev F.
    Phys Chem Chem Phys; 2015 May 28; 17(20):13403-20. PubMed ID: 25927714
    [Abstract] [Full Text] [Related]

  • 8. Cross-talk between the ligand- and DNA-binding domains of estrogen receptor.
    Huang W, Greene GL, Ravikumar KM, Yang S.
    Proteins; 2013 Nov 28; 81(11):1900-9. PubMed ID: 23737157
    [Abstract] [Full Text] [Related]

  • 9. Ligand unbinding from the estrogen receptor: a computational study of pathways and ligand specificity.
    Burendahl S, Danciulescu C, Nilsson L.
    Proteins; 2009 Dec 28; 77(4):842-56. PubMed ID: 19626711
    [Abstract] [Full Text] [Related]

  • 10. Conformational and dynamics changes induced by bile acids binding to chicken liver bile acid binding protein.
    Eberini I, Guerini Rocco A, Ientile AR, Baptista AM, Gianazza E, Tomaselli S, Molinari H, Ragona L.
    Proteins; 2008 Jun 28; 71(4):1889-98. PubMed ID: 18175325
    [Abstract] [Full Text] [Related]

  • 11. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM, ter Laak AM, Jongejan A, Vermeulen NP, Wamelink M, Geerke D, Meerman JH.
    J Med Chem; 2004 Feb 12; 47(4):1018-30. PubMed ID: 14761204
    [Abstract] [Full Text] [Related]

  • 12. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.
    J Med Chem; 2005 Jan 27; 48(2):364-79. PubMed ID: 15658851
    [Abstract] [Full Text] [Related]

  • 13. Only subtle protein conformational adaptations are required for ligand binding to thyroid hormone receptors: simulations using a novel multipoint steered molecular dynamics approach.
    Martínez L, Polikarpov I, Skaf MS.
    J Phys Chem B; 2008 Aug 28; 112(34):10741-51. PubMed ID: 18681473
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Molecular switch in the glucocorticoid receptor: active and passive antagonist conformations.
    Schoch GA, D'Arcy B, Stihle M, Burger D, Bär D, Benz J, Thoma R, Ruf A.
    J Mol Biol; 2010 Jan 22; 395(3):568-77. PubMed ID: 19913032
    [Abstract] [Full Text] [Related]

  • 16. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
    Elhaji YA, Stoica I, Dennis S, Purisima EO, Lumbroso R, Beitel LK, Trifiro MA.
    Hum Mol Genet; 2006 Mar 15; 15(6):921-31. PubMed ID: 16449235
    [Abstract] [Full Text] [Related]

  • 17. Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.
    J Med Chem; 2003 Jul 03; 46(14):2945-57. PubMed ID: 12825935
    [Abstract] [Full Text] [Related]

  • 18. Three-dimensional models of estrogen receptor ligand binding domain complexes, based on related crystal structures and mutational and structure-activity relationship data.
    Wurtz JM, Egner U, Heinrich N, Moras D, Mueller-Fahrnow A.
    J Med Chem; 1998 May 21; 41(11):1803-14. PubMed ID: 9599231
    [Abstract] [Full Text] [Related]

  • 19. Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.
    Shen J, Li W, Liu G, Tang Y, Jiang H.
    J Phys Chem B; 2009 Jul 30; 113(30):10436-44. PubMed ID: 19583238
    [Abstract] [Full Text] [Related]

  • 20. Structural basis for an unexpected mode of SERM-mediated ER antagonism.
    Wu YL, Yang X, Ren Z, McDonnell DP, Norris JD, Willson TM, Greene GL.
    Mol Cell; 2005 May 13; 18(4):413-24. PubMed ID: 15893725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.